BioSpecifics Technologies Stock Price (NASDAQ:BSTC)

Add to My Stocks
$58.17 $0.06 (0.1%) BSTC stock closing price Sep 19, 2018 (Closing)
Prev Close* : $58.23
Market Cap:
$424.78M
Day Low: $54.02
52 Week Low: $38.05
Open: $58.3
Volume: -
Day High: $58.46
52 Week High: $62.50
Dividend:
0.00

Latest Stock Market News

Latest Articles

BioSpecifics Technologies News - From Partners

BSTC Stockcharts

View BSTC PE ratio, PS ratio stocks charts and compare with peers.
BSTC Chart
Note: Compare BioSpecifics Technologies stock price history with the index and industry peers.

BioSpecifics Technologies Valuation

PE ratio
(price earnings ratio)
31.27
PS ratio (
price to sales ratio
)
15.32
PB ratio (
price to book ratio
)
5.78

BioSpecifics Technologies Returns

ROE
(return on equity)
19%

BioSpecifics Technologies Financial Ratios

Asset Turnover
0.32
Receivables Turnover
2.96
Debt to Equity
0
Dividend Yield
0%

BSTC Industry Peers

Company Price Change (%)
Aquestive Thera (AQST)16.380.31 (1.93%)
Dermira (DERM)10.820.04 (0.37%)
Auxilium Pharma (AUXL)36.470.06 (0.16%)
Lipocine (LPCN)1.570.01 (0.63%)
Nephrogenex (NRXGQ)00 (0%)
Fibrogen (FGEN)56.31.05 (1.83%)
Palatin Technologies (PTN)1.030.01 (0.98%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Neptune Tech. & Bio. (NEPT)4.710.44 (10.3%)
Infinity Pharma (INFI)2.310.18 (8.45%)
Pacira Pharma (PCRX)51.353.5 (7.31%)
Aratana Therapeutics (PETX)5.840.39 (7.16%)
Achaogen (AKAO)4.560.28 (6.54%)
La Jolla Pharma (LJPC)22.071.12 (5.35%)
Top gainers from Medical-Drugs industry
* As of Sep 20, 2018
CompanyPriceChange (%)
PTC Therapeutics (PTCT)45.371.82 (3.86%)
USANA Health Sciences (USNA)119.354.75 (3.83%)
Esperion Therapeutics (ESPR)45.571.69 (3.58%)
ArQule (ARQL)4.850.17 (3.39%)
Zogenix (ZGNX)47.051.6 (3.29%)
Nektar Therapeutics (NKTR)56.691.64 (2.81%)
Durect (DRRX)1.10.03 (2.65%)
Top losers from Medical-Drugs industry
* As of Sep 20, 2018

BioSpecifics Technologies Corp. Stock News - Partner Headlines

BioSpecifics Technologies Financial Statements

income statement20172016201520142013
Net Sales or Revenues27.44M26.25M22.75M14.07M14.46M
Net Income11.32M11.37M9.61M4.64M5.28M
Total Operating Expense9.76M9.21M8.3M7.07M6.51M
View BioSpecifics Technologies income statement
balance sheet20172016201520142013
Total Assets74.99M64.69M45.69M31.02M23.25M
Total Liabilities7.47M8.41M---
Shareholders Equity67.51M56.28M44.81M30.25M22.33M
View BioSpecifics Technologies balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-2.08M5.82M-0.5M--0.31M
Net Cash from (used by) Operating Activities13.15M16.35M10.6M6.12M5.13M
Increase (Decrease) in Prop Plant And Equipment-----
View BioSpecifics Technologies cash flow statement

BioSpecifics Technologies Stock Message Board

BioSpecifics Technologies stock lost 0.1%, and the last close price as of Sep 19, 2018 is $58.17 for BSTC stock. Looking at BioSpecifics Technologies market capitalization, which currently stands at $424.78M, we can say that BSTC stock is a Small Cap stock. BioSpecifics Technologies valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: BioSpecifics Technologies stock price and BioSpecifics Technologies share price mean the same thing. 28,201 shares were traded with a closing stock price of $58.17 as of Sep 19, 2018, as can be seen from BioSpecifics Technologies stock quote. One can view BioSpecifics Technologies stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. BioSpecifics Technologies does not pay dividends. BioSpecifics Technologies stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.